We are live on
!
Find out more
KLCMU
Kite Lake Capital Management (UK) Portfolio holdings
AUM
$290M
1-Year Est. Return
183.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.19%
1 Year Est. Return
+183.72%
3 Year Est. Return
+337.34%
5 Year Est. Return
+421.47%
10 Year Est. Return
–
AUM
$31.6M
AUM Growth
-$1.38B
(-98%)
Cap. Flow
-$171M
Cap. Flow
% of AUM
-541.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
1
Reduced
–
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$10.1M |
| 2 |
Qiagen
QGEN
|
+$6.33M |
| 3 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$78.8M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$34.9M |
| 3 |
VSM
Versum Materials, Inc.
VSM
|
+$26.8M |
| 4 |
Pacific Biosciences
PACB
|
+$19M |
| 5 |
PVTL
Pivotal Software, Inc.
PVTL
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.78% |
| 2 | Miscellaneous | 4.22% |
| 3 | Consumer Discretionary | 0% |
| 4 | Industrials | 0% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPO
1
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $24.1M | 76.46% |
207,382
+86,809
| +72% | +$10.1M |
|
|
2
Qiagen
QGEN
$8.86B
| $6.1M | 19.32% |
+170,179
| New | +$6.33M |
|
|
BMY.RT
3
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $1.33M | 4.22% |
+442,340
| New | +$1.15M |
|
|
4
Pacific Biosciences
PACB
$417M
| – | – |
-3,689,527
| Closed | -$19M |
|
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| – | – |
-406,100
| Closed | -$1.21B |
|
|
WBC
6
DELISTED
WABCO HOLDINGS INC.
WBC
| – | – |
-588,899
| Closed | -$78.8M |
|
|
GWR
7
DELISTED
Genesee & Wyoming Inc.
GWR
| – | – |
-128,384
| Closed | -$14.2M |
|
|
PVTL
8
DELISTED
Pivotal Software, Inc.
PVTL
| – | – |
-979,423
| Closed | -$14.6M |
|
|
ONCE
9
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – |
-359,793
| Closed | -$34.9M |
|
|
VSM
10
DELISTED
Versum Materials, Inc.
VSM
| – | – |
-506,989
| Closed | -$26.8M |
|
Similar funds
SIA
MPWS
RC
FCMI
NWP
VIP
BCP
NC
Kite Lake Capital Management (UK)'s Q4 2019 Portfolio in Review
As of Q4 2019, Kite Lake Capital Management (UK) held 10 positions worth $31.6M, down 98% from $1.41B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Kite Lake Capital Management (UK) withdrew a net $171M in Q4 2019, closing 7 positions. Its most notable exit was WABCO HOLDINGS INC., an estimated $78.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 4.8% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
Against the trend, Kite Lake Capital Management (UK) opened a new position in Qiagen worth $6.1M.
- Kite Lake Capital Management (UK)'s largest Q4 2019 buy was Qiagen: 170,179 shares worth $6.1M.
- Kite Lake Capital Management (UK) added most to China Biologic Products Holdings, Inc. in Q4 2019, an estimated $10.1M increase.
- Kite Lake Capital Management (UK) fully exited WABCO HOLDINGS INC. in Q4 2019, selling an estimated $78.8M.
- Kite Lake Capital Management (UK)'s ten largest holdings make up 100% of its $31.6M portfolio in Q4 2019.
- Kite Lake Capital Management (UK) opened 2 new positions and closed 7 in Q4 2019.
- Kite Lake Capital Management (UK)'s portfolio value fell 98% quarter-over-quarter to $31.6M.
Based on Kite Lake Capital Management (UK)'s 13F filing for Q4 2019, filed 14 Feb 2020.